Dr. Paula Berstad, PhD, is a senior researcher at the Cancer Registry of Norway, the Norwegian Institute for Public Health. She focuses on cancer prevention, particularly colorectal cancer screening. Her research explores integrating lifestyle assessments into screening to improve risk stratification and personalized prevention. She also studies the interaction between the gut microbiome and lifestyle factors in colorectal cancer development, as well as barriers to screening participation, emphasizing disparities in immigrant populations.

Dr. Marjolein Greuter focuses on the optimalisation of colorectal cancer screening and surveillance using health-economic modeling.

I am a PhD fellow specializing in cervical cancer screening among HPV-vaccinated women. My research focuses on Trial23, a cohort of Danish women born in 1994 who received the quadrivalent HPV vaccine in 2008 and were first screened in 2017. This study compares HPV testing and cytology as screening methods, with additional genotyping of CIN2+ cases to provide deeper insights. Through this work, I aim to enhance cervical cancer prevention strategies for vaccinated populations.

Lindy Kregting is a postdoctoral researcher and epidemiologist in the field of breast and cervical cancer screening working at Radboudumc, Nijmegen, the Netherlands. At the moment she is involved in a project on further personalising the triage of cervical cancer screening and a project on the short, medium and long term effects of tomosynthesis in the Dutch breast cancer screening programme. During her PhD, she worked on the evaluation and Dutch breast cancer screening programme at Erasmus MC, Rotterdam.

Iakovos Toumazis is an Assistant Professor at the Department of Health Services Research, at The University of Texas MD Anderson Cancer Center. His research is currently supported by the NCI and the Cancer Prevention and Research Institute of Texas (CPRIT), among others. Dr. Toumazis is an active member of the Cancer Intervention and Surveillance Modeling Network (CISNET) Lung Working Group and of the American Cancer Society (ACS) National Lung Cancer Roundtable (NLCRT) Shared Decision-Making Task Group. His research interests include sequential decision making under uncertainty, applications of operations research in healthcare, simulation modeling, and cost-effectiveness analyses of cancer interventions.

PhD Candidate ErasmusMC medical center researching prostate cancer screening in Europe.

Statistician, Servizio di Epidemiologia e Comunicazione del Rischio (Epidemiology Unit). I deal with population based studies and epidemiological analyses based on census data and administrative health databases mainly on cancer and cancer screening. I collaborated on data collection, armonization and statistics analysis of the national multicentre trial on Cervical Cancer screening (New Technologies for Cervical Cancer Screening 2; Umbria Cohort study) and on breast cancer screening technologies and risk stratification (Reggio Emilia Tomosynthesis trial, MyPeBS international trial, Risk prediction with Karolinska Institute).

"Hana Zahed is a postdoctoral scientist at the International Agency for Research on Cancer (IARC/WHO) France with the Risk Assessment and Early Detection team. Her research focuses on optimizing lung cancer screening programs by utilizing integrative approaches combining traditional and molecular epidemiology using protein biomarkers.